期刊文献+

低氧对肿瘤干细胞增殖及耐药作用的分子机制 被引量:2

下载PDF
导出
摘要 低氧是多种肿瘤存在的基本生物学现象,参与构成复杂的肿瘤发展和侵袭的微环境。低氧环境下,低氧诱导因子(HIF)及其相关信号通路通过调节细胞的增殖、生存和代谢,精确的调控了肿瘤的侵袭、转移和化疗抵抗。同时也解释了肿瘤干细胞通过HIF依赖的方式获得自我更新的干细胞特性以及上皮间质转化特征。本文讨论了低氧及HIF信号通路参与调节肿瘤干细胞增殖和耐药的分子机制,及其在防治肿瘤复发、转移中的意义。
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2013年第10期1113-1116,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(81000958) 宁夏自然科学基金(NZ09132) 宁夏医科大学科研项目(XQ2011023)
  • 相关文献

参考文献35

  • 1Zhang L, Jiao M, Li L, et al. Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties [J]. J Cancer Res Clin Oncol, 2012, 138(4) : 675 -686.
  • 2Piao LS, Hur W, Kim TK, et al. CD133 liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma [ J ]. Cancer Lett, 2012, 315(2): 129-137.
  • 3Beea FF, Caetano P, Gerhard R, et al. Cancer stem cells markers CIM4, CIY24 and ALDH1 in breast cancer special histological types [J]. J Clin Pathol, 2013, 66(3): 187 -191.
  • 4A1-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells [ J ]. Proc Natl Acad Sci U S A, 2003, 100(7) : 3983 -3988.
  • 5Ma S. Biology and clinical implications of CD133 liver cancer stem cells[ J]. Exp Cell Res, 2013, 319(2) : 126 -132.
  • 6Tang KH, Ma S, Lee TK, et al. CD133 liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neumtensin/interleukin-8/CXCL1 signaling[ J]. Hepatology, 2012, 55(3) : 807 -820.
  • 7Nishikawa S, Konno M, Hamabe A, et al. Aldehyde dehydrogenase- high gastric cancer stem cells are resistant to chemotherapy[ J]. Int J Oncol, 2013, 42(4) : 1437 - 1442.
  • 8Favaro E, Lord S, Harris AL, et al. Gene expression and hypoxia in breast cancer[J/OA]. Genome Med, 2011, 3(8) : 55.
  • 9Carmeliet P and Jain RK. Molecular mechanisms and clinical applications of angiogenesis [ J ]. Nature, 2011,473 (7347) : 298 - 307.
  • 10Welford SM and Giaccia AJ. Hypoxia and senescence: the impact of oxygenation on tumor suppression [ J ]. Mol Cancer Res, 2011, 9 (5) : 538 -544.

同被引文献26

  • 1Malik B, Nie D. Cancer stem cells and resistance to chemo and radio therapy [J]. Front Biosci (Elite Ed), 2012, 4:2142 -2149.
  • 2Gottschling S, Schnabel PA, Herth FJ, et al. Are we missing the target-Cancer stem cells and drug resistance in non-small cell lung cancer [J]. Cancer Genomics Proteomics, 2012, 8(9) : 275 -286.
  • 3Sampieri K, Fodde R. Cancer stem cells and metastasis [J]. Semin Cancer Biol, 2012, 17(22) : 187 -193.
  • 4Ciurea ME, Georgescu AM, Purcaru SO, et al. Cancer stem cells: biological functions and therapeutically targeting[ J]. Int J Mol Sci, 2014, 15(5): 8169-8185.
  • 5Nosrati A, Naghshvar F, Khanari S. Cancer stem cell markers CD44, CD133 in primary gastric adenocarcinoma[ J]. Int J Mol Cell Med, 2014, 3(4) : 279 -286.
  • 6Bhullar KS, Hubbard BP. Lifespan and heahhspan extension by resveratrol [J]. Biochim Biophys Acta, 2015, 1852(6) : 1209 -1218.
  • 7Summerlin N, Soo E, Thakur S, et al. Resveratrol nanoformulations: Challenges and opportunities [ J]. Int J Pharm, 2015, 479 ( 2 ) : 282 - 290.
  • 8Baena R, Salinas P. Diet and colorectal cancer [ J ]. Maturitas,2015, 80(3) : 258 -264.
  • 9Chela S, Huang EH. The colon cancer stem eel/ holds keys to future cancer therapy [ J ]. J Gastrointest Surg, 2014, 18(5) : 1040 -1048.
  • 10Zeuner A, Todaro M, Stassi G, et al. Colorectal cancer stem cells: from the crypt to the clinic[J]. Cell Stem Cell, 2014, 15 (6): 692 - 705.

引证文献2

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部